日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study

STRONG II 试验:不可切除的肝门部胆管癌化疗后立体定向放射治疗——一项单臂多中心 II 期研究

van Loosbroek, Suus Y; Milder, Maaike T W; de Ruysscher, Dirk; Vaes, Rianne D W; den Toom, Wilhelm; Willemssen, François; Eskens, Ferry; Homs, Marjolein Y V; Groot Koerkamp, Bas; van Driel, Lydi M J W; Seppenwoolde, Yvette; van Werkhoven, Erik; Intven, Martijn; Haj Mohammad, Nadia; de Bruijne, Joep; Versteijne, Eva; Bruynzeel, Anna M; Brandts, Freek; Erdmann, Joris I; Westdorp, Harm; Braam, Pètra M; Tjwa, Eric T T L; Bouchart, Christelle; Demols, Anne; Gulyban, Akos; Buijsen, Jeroen; de Vos-Geelen, Judith; Dewulf, Maxime; Joye, Ines; Vandamme, Timon; Vonghia, Luisa; de Groot, Derk Jan; Dieters, Margriet; Ubbels, Fred J F; Hoogwater, Frederik J H; Heijmen, Ben; Méndez Romero, Alejandra PHD

A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas

胆道和胰腺腺癌中 NTRK 基因融合检测的两步诊断方法

Anne Demols, Laureen Rocq, Luis Perez-Casanova, Manon Charry, Nancy De Nève, Ali Ramadhan, Claude Van Campenhout, Sarah De Clercq, Calliope Maris, Jean Closset, Valerio Lucidi, Isabelle Salmon, Nicky D'Haene

CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges

CDK4/6抑制剂在胰胆肿瘤治疗中的应用:机遇与挑战

Arsenijevic, Tatjana; Coulonval, Katia; Raspé, Eric; Demols, Anne; Roger, Pierre P; Van Laethem, Jean-Luc

The impact of a multidisciplinary team approach on the management of focal pancreatic lesions: a single tertiary center experience

多学科团队协作模式对局灶性胰腺病变管理的影响:一家三级医疗中心的经验

Francisse, Sophie; Gkolfakis, Paraskevas; Viesca, Michael Fernandez Y; Mans, Laura; Demols, Anne; Pezzullo, Martina; Loi, Patricia; Navez, Julie; Closset, Jean; Bali, Maria Antonietta; Wettere, Morgane Van; D'Haene, Nicki; Demetter, Pieter; Verset, Laurine; Bouchart, Christelle; Lemmers, Arnaud; Deviere, Jacques; Delhaye, Myriam; Laethem, Jean-Luc Van; Arvanitakis, Marianna

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

一项针对接受铂类化疗后病情进展的肛管鳞状细胞癌患者的 retifanlimab (INCMGA00012) II 期研究 (POD1UM-202)

Rao, S; Anandappa, G; Capdevila, J; Dahan, L; Evesque, L; Kim, S; Saunders, M P; Gilbert, D C; Jensen, L H; Samalin, E; Spindler, K-L; Tamberi, S; Demols, A; Guren, M G; Arnold, D; Fakih, M; Kayyal, T; Cornfeld, M; Tian, C; Catlett, M; Smith, M; Spano, J-P